Suven Life Sciences share news and announcements
NSE: SUVENBSE: 530239Healthcare ServicesSmall Cap
Last close ₹261.35down ₹6.85 (2.55%)BSE ₹261.80
Share price at the NSE close on 23 Oct 2026. Previous close ₹268.20.
52-week range of traded prices to 23 Oct 2026
₹124.11Low, 24 Mar 2026₹403.35High, 1 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹7,385 Cr806th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −100.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −63.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 10,72,06841.2% delivered
Suven Life Sciences orders, deals and press releases
305 filed, newest first. Page 6 of 7.
Jun 2010
May 2010
5 May · Business
Compensation Committee of Board of Directors of the Company allotted 6,61,848 equity shares through circular resolution on May 05, 2010 under stock option plans of the company. Further, consequent to the above allotment, the paid up share capital of the company has gone up from 115874400 equity shares of Re 1/- each, aggregating to Rs. 11,58,74,400 to 116536248 equity shares of Re 1/- each aggregating to Rs 11,65,36,248.
Apr 2010
28 Apr · Business
Press release dated April 28, 2010, titled "Suven Life Sciences secures Product Patents from India and New Zealand ". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Apr · Business
Press release dated April 22, 2010, titled "Suven Life Sciences secures Three Australian Patents on NCEs". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Apr · Business
Press release dated April 12, 2010, titled "Suven Life Sciences secures First Product Patent from Japanese Patent Office (JPO) for their NCE to treat Central Nervous System (CNS) disorders." A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Mar 2010
29 Mar · Business
Press release dated March 29, 2010, titled "Suven Life Sciences secures 8th product patent from European Patent Office (EPO) for their NCE to treat Central Nervous System (CNS) disorders". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Mar · Business
Press release dated March 22, 2010, titled "Suven Life Sciences secures 5th Product Patent from US patent office for their NCE to treat Central Nervous System (CNS) disorders". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2010
27 Jan · Business
Press release dated January 27, 2010, titled " Suven Spend 34 % of Revenue on R & D for the 3rd Quarter ending Dec' 09". A copy of the press release shall be available on the NSE website http://www.nseindia.com) under: Corporates > Latest announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Jan · Business
Press release dated January 12, 2010, titled " Suven Secures Two product patents in China and Russia". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Dec 2009
14 Dec · Business
Press release dated December 14, 2009, titled " Suven Secures two Product patents from Canadian Intellectual Property Office."A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2009
30 Nov · Business
Press release dated November 30, 2009, titled "Suven Life Sciences secures Three European Patents on NCEs". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2009
31 Oct · Business
Press release dated October 31, 2009, titled "Suven spends 29.78% of Revenue on R&D for the quarter ending Sep 09". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 Oct · Business
Press release dated October 20, 2009, titled "Suven Life Sciences presenting Pre-clinical data of their NCEs at Society for Neuroscience Annual Meeting, SFN-2009 at Chicago, USA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.14 Oct · Business
Press release dated October 14, 2009, titled "Suven's Clinical Candidate SUVN-502 For Alzheimer's disease Secures product patents in several Key markets in the world". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2009
15 Sep · Business
Press release dated September 14, 2009, titled "Suven Life Sciences secures Two US Patents on NCEs". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
28 Jul · Business
Press release dated July 28, 2009, titled "Suven's profit up by 37%, Spends 22% of Revenue on R&D". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.27 Jul · Business
Press release dated July 27, 2009, titled "Suven Presented Positive Phase-I clinical data of SUVN-502 for Alzheimer's disease at ICAD 2009, Vienna, Austria". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2009
6 May · Business
Press release dated May 06, 2009, titled "Suven's Unit - I Receives US FDA Acceptance". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2009
29 Apr · Business
Press release dated April 29, 2009, titled "Suven's revenue up by 19%, Spends 22% of Revenue on R&D". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.9 Apr · Business
Press release dated April 09, 2009, titled "Suven completes Phase I Clinical Trials Multiple Ascending Dose of SUVN-502 in Switzerland". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
19 Jan · Business
Press release dated January 19, 2009, titled "Suven's revenue up by 21%, Spends 24% of Revenue on R&D". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 Jan · Business
Press release dated January 13, 2009, titled ""Suven Particiapation at Biotech Showcase 2009" SanFrancisco, USA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2008
18 Nov · Business
Press release dated November 18, 2008, titled "Suven Life Sciences presenting Biology data of their NCE's at Society for Neuroscience Annual Meeting, SFN-2008 at Washington DC, USA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.11 Nov · Business
Press release dated November 11, 2008, titled "Suven Presentation at Rodman & Renshaw 10th Annual Healthcare Conference at New York being held from 10-12 November 2008". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2008
31 Oct · Business
Press release dated October 31, 2008, titled "Suven's net up by 50%, Spends 17% of Revenue on R&D". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 Oct · Business
Press release dated October 13, 2008, titled "SUVN-502 data being presented at 16th BioPartnering in London". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2008
29 Sep · Business
Press release dated September 29, 2008, titled "Suven completed Phase-I Clinical Trials Single Ascending Dose of SUVN-502 in Switzerland". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.25 Sep · Business
Press release dated September 25, 2008, titled " DCGI nod to conduct Phase-I Clinical Trials of SUVN-502 for Alzheimer's disease". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2008
12 Aug · Business
Press release dated August 12, 2008, titled "Asian Clinical Trials (ACT), the CRO division of Suven commences clinical research services from Raleigh, North Carolina, USA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Aug · Business
Press release dated August 04, 2008, titled "Suven Life Sciences Presents Positive Preclinical Data for SUVN-502 at Alzheimer's conference, Chicago and Drug Discovery conference, Boston". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
25 Jul · Business
Press release dated July 25, 2008, titled "Revenue growth for quarter at 11.43%, Commences Phase 1 clinical trial of SUVN-502 in Switzerland for Alzheimer's Disease". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.7 Jul · Business
Press release dated July 07, 2008, titled "Suven Life Sciences Clinical candidate SUVN-502 being presented at International Conference on Alzheimer's Disease, ICAD-2008 at Chicago, USA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2008
18 Jun · Business
Press release dated June 18, 2008, titled "Suven Life Sciences Initiates Phase I Clinical Trials in Europe of SUVN-502 for Alzheimer's disease". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2008
27 May · Business
Press release dated May 27, 2008, titled "Suven Life Sciences gets Two product patents for NCEs in Russia and Australia". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 May · Business
Press release dated May 20, 2008, titled "Suven Life Sciences gets Two product patents for NCEs in South Africa and China". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.5 May · Business
Press release dated May 05, 2008, titled "Suven's Clinical Candidate SUVN-502 Secures European product patent". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2008
8 Apr · Business
Press release dated April 08, 2008, titled "Suven Life Sciences' ACT Enters into an Alliance with VPSCRO". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Mar 2008
31 Mar · Business
Press release dated March 31 , 2008, titled "Suven Life Sciences gets Two product patents in Korea and Mexico". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Mar · Business
Press release dated March 24 , 2008, titled "Suven Life Sciences secures Two Products Patents in all Russian countries (Eurasia Region)". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Mar · Business
Press release dated March 12 , 2008, titled "Suven Establishes Second CNS Drug Discovery Collaboration with Lilly". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2008
23 Jan · Business
Press release dated January 23, 2008, titled "Suven Obtains 2nd Product Patent from US Patent office". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Dec 2007
27 Dec · Business
Press release dated December 27, 2007, titled "Suven Obtains 1st Product Patent from US Patent office". A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.11 Dec · Business
Press release dated December 11, 2007 titled "Suven presenting at Windhover's Bio/Pharma Partnerships conference in San Francisco". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2007
27 Nov · Business
Press release dated November 27, 2007, titled "Suven Life Sciences secures two Product Patents from European Patent Office (EPO) for the treatment of Neurodegenerative diseases". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.5 Nov · Business
Press release dated November 05, 2007, titled "Suven Life Sciences presenting Pre-clinical data of their NCEs at Society for Neuroscience Annual Meeting, SFN-2007 at San Diego, USA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2007
31 Oct · Business
Press release dated October 31, 2007, titled "Suven Life Sciences secures Two (2) Product Patents in Australia & New Zealand for Their New Chemical Entities (NCEs)". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.25 Oct · Business
Press release dated October 25, 2007, titled "Suven enters into collaboration with University of Minnesota to develop Drugs to treat HIV infection". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2007
12 Jul · Business
Press release dated July 12, 2007, titled "Suven Life Sciences files its first Investigational New Drug (IND) application of its NCE SUVN-502 in India to conduct Phase 1 clinical trials". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.